dactinomycin has been researched along with Opportunistic Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessho, M; Endo, K; Fukuda, M; Kawai, N; Maesaki, S; Takinami, S; Tominaga, K; Yamazaki, T | 1 |
1 trial(s) available for dactinomycin and Opportunistic Infections
Article | Year |
---|---|
[Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Treatment Outcome | 2001 |